Bloom Public Health and Merck Life Science have signed a memorandum of understanding aimed at strengthening the capacity of the National Quality Control Laboratories of different countries in English speaking sub-Saharan Africa to achieve both ISO Certification and WHO prequalification, amongst other things.
Merck Life Science which has its headquarters in Germany is a leading supplier to the global Life Science industry: solutions and services for research, development, and production of biotechnology and pharmaceutical drug therapies.
The agreement also aims to support the implementation of current Good Laboratory Practices (cGLPs), current Good Manufacturing Practices (cGMPs) to boost the capacity of Pharmaceutical/Vaccine/Biopharmaceutical manufacturing across industries in Sub-Sahara English Africa.
The CEO, Bloom Public Health, Professor Chimezie Anyakora said, “this MoU is a great effort at knowledge transfer in these modern times for Africa. We will channel the repository of expertise at Merck Life Science and transfer that to the entire pharmaceutical which include the academia, manufacturing sector, regulatory agencies and private laboratories. This partnership will provide Africa the opportunity to bridge the knowledge gap and leverage the technical support required for the African pharmaceutical sector to align with global best practices. We are pleased to have Merck Life Science on board as we continue to take actions to ensure an African Pharmaceutical sector reform.”
In line with this vision of bridging the expertise gap on the continent Bloom Public Health and Merck Life Science will be hosting a bi-weekly webinar series beginning on the 13th of August, 2020. These webinars are opened regulators, academia and manufacturers in the pharmaceutical space. Our first webinar will be on ‘HPLC for Pharmaceutical Analyses: Succeed with Sample Filtration’ to be given by Dr. Vivek Joshi and Ahmed Werida.